2012 Q1 Form 10-Q Financial Statement

#000144530512001771 Filed on May 15, 2012

View on sec.gov

Income Statement

Concept 2012 Q1 2011 Q4 2011 Q1
Revenue $70.68M $65.53M $70.89M
YoY Change -0.3% -1.31% 12.53%
Cost Of Revenue $28.30M $28.20M $27.40M
YoY Change 3.28% 8.46% 13.22%
Gross Profit $47.70M $47.00M $43.70M
YoY Change 9.15% 16.63% 12.63%
Gross Profit Margin 67.49% 71.72% 61.64%
Selling, General & Admin $5.200M $4.400M $6.000M
YoY Change -13.33% 0.0% 33.33%
% of Gross Profit 10.9% 9.36% 13.73%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $16.70M $25.00M $21.90M
YoY Change -23.74% 22.55% 16.49%
% of Gross Profit 35.01% 53.19% 50.11%
Operating Expenses $28.10M $27.00M $26.00M
YoY Change 8.08% 14.89% 18.18%
Operating Profit $10.45M $11.73M $11.91M
YoY Change -12.3% -30.17% -29.08%
Interest Expense -$18.10M -$18.30M -$22.10M
YoY Change -18.1% 5.78% 38.99%
% of Operating Profit -173.22% -156.0% -185.5%
Other Income/Expense, Net -$11.01M -$9.724M -$9.724M
YoY Change 13.18%
Pretax Income $1.400M $1.700M -$6.400M
YoY Change -121.88% -525.0% -1700.0%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income 0.0% 0.0%
Net Earnings -$315.0K $1.995M $2.150M
YoY Change -114.65% 398.75% -53.26%
Net Earnings / Revenue -0.45% 3.04% 3.03%
Basic Earnings Per Share $0.00 $0.00 $0.01
Diluted Earnings Per Share $0.00 $0.00 $0.01
COMMON SHARES
Basic Shares Outstanding 228.9M shares 227.8M shares 214.8M shares
Diluted Shares Outstanding 228.9M shares 228.3M shares 215.0M shares

Balance Sheet

Concept 2012 Q1 2011 Q4 2011 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $6.600M $4.700M $3.000M
YoY Change 120.0% -95.85% -72.73%
Cash & Equivalents $35.12M $69.49M $207.4M
Short-Term Investments
Other Short-Term Assets $44.90M $45.10M
YoY Change
Inventory
Prepaid Expenses
Receivables $6.500M $7.600M $15.00M
Other Receivables $32.30M $30.40M $0.00
Total Short-Term Assets $90.30M $87.80M $3.000M
YoY Change 2910.0% -22.51% -72.73%
LONG-TERM ASSETS
Property, Plant & Equipment $2.252B $2.272B $2.092B
YoY Change 7.66% 8.86% 15.66%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $1.300M $1.300M
YoY Change
Other Assets $26.80M $42.40M $16.70M
YoY Change 60.48% 77.41% 943.75%
Total Long-Term Assets $2.367B $2.204B $2.294B
YoY Change 3.21% 2.1% 19.36%
TOTAL ASSETS
Total Short-Term Assets $90.30M $87.80M $3.000M
Total Long-Term Assets $2.367B $2.204B $2.294B
Total Assets $2.458B $2.292B $2.297B
YoY Change 7.01% 0.87% 18.83%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $47.00M $72.20M $55.80M
YoY Change -15.77% 15.15% -5.1%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $47.00M $72.20M $55.80M
YoY Change -15.77% 15.15% -5.1%
LONG-TERM LIABILITIES
Long-Term Debt $1.419B $1.394B $1.293B
YoY Change 9.71% -1.02% 24.93%
Other Long-Term Liabilities $52.30M $50.50M $45.40M
YoY Change 15.2% 14.51% -1.52%
Total Long-Term Liabilities $1.471B $1.444B $1.339B
YoY Change 9.89% -0.55% 23.8%
TOTAL LIABILITIES
Total Short-Term Liabilities $47.00M $72.20M $55.80M
Total Long-Term Liabilities $1.471B $1.444B $1.339B
Total Liabilities $918.1M $720.5M $1.394B
YoY Change -34.15% -7.71% 21.88%
SHAREHOLDERS EQUITY
Retained Earnings -$509.1M -$467.2M
YoY Change 50.63%
Common Stock $2.045B $2.035B
YoY Change 13.19%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.536B $1.567B $1.657B
YoY Change
Total Liabilities & Shareholders Equity $2.458B $2.292B $2.297B
YoY Change 7.01% 0.87% 18.83%

Cashflow Statement

Concept 2012 Q1 2011 Q4 2011 Q1
OPERATING ACTIVITIES
Net Income -$315.0K $1.995M $2.150M
YoY Change -114.65% 398.75% -53.26%
Depreciation, Depletion And Amortization $16.70M $25.00M $21.90M
YoY Change -23.74% 22.55% 16.49%
Cash From Operating Activities $26.11M $40.70M $25.11M
YoY Change 3.96% 116.49% -11.27%
INVESTING ACTIVITIES
Capital Expenditures -$44.50M $31.40M -$25.50M
YoY Change 74.51% -123.91% 0.79%
Acquisitions
YoY Change
Other Investing Activities $33.80M -$76.30M -$45.00M
YoY Change -175.11% 10.74% -357.14%
Cash From Investing Activities -$220.8M -$45.00M -$28.47M
YoY Change 675.55% -77.52% 269.77%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $9.916M -$202.3M
YoY Change -104.9% -1448.63%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $160.3M 5.100M $181.5M
YoY Change -11.66% -98.2% -1278.55%
NET CHANGE
Cash From Operating Activities $26.11M 40.70M $25.11M
Cash From Investing Activities -$220.8M -45.00M -$28.47M
Cash From Financing Activities $160.3M 5.100M $181.5M
Net Change In Cash -$34.37M 800.0K $178.1M
YoY Change -119.29% -99.22% 3325.67%
FREE CASH FLOW
Cash From Operating Activities $26.11M $40.70M $25.11M
Capital Expenditures -$44.50M $31.40M -$25.50M
Free Cash Flow $70.61M $9.300M $50.61M
YoY Change 39.51% -93.8% -5.58%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2012Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Nonvested Shares Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationNonvestedSharesRequisiteServicePeriodRecognition
1002000 USD
CY2011Q1 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
15002000 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
69491000 USD
CY2011Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
47801000 USD
CY2010Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
29270000 USD
CY2011Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
207405000 USD
CY2012Q1 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
43244000 USD
CY2011Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
178135000 USD
CY2011Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2032305000 USD
CY2012Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2042528000 USD
CY2012Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-34371000 USD
CY2011Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Nonvested Shares Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationNonvestedSharesRequisiteServicePeriodRecognition
897000 USD
CY2011Q4 us-gaap Assets
Assets
2291629000 USD
CY2012Q1 us-gaap Assets
Assets
2457596000 USD
CY2011Q1 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
1062000 USD
CY2012Q1 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
2321000 USD
CY2012Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2578000 USD
CY2011Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2789000 USD
CY2012Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
35120000 USD
CY2011Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2012Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2011Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2012Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2011Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2012Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2012Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
229514049 shares
CY2011Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
228491312 shares
CY2012Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
229514049 shares
CY2011Q4 us-gaap Liabilities
Liabilities
720504000 USD
CY2012Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2457596000 USD
CY2011Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
228491312 shares
CY2011Q4 us-gaap Common Stock Value
CommonStockValue
2284000 USD
CY2012Q1 us-gaap Common Stock Value
CommonStockValue
2295000 USD
CY2012Q1 us-gaap Costs And Expenses
CostsAndExpenses
60544000 USD
CY2011Q1 us-gaap Costs And Expenses
CostsAndExpenses
58978000 USD
CY2012Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
27357000 USD
CY2011Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
26750000 USD
CY2011Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
1792000 USD
CY2012Q1 us-gaap Derivative Liabilities
DerivativeLiabilities
2270000 USD
CY2011Q1 us-gaap Direct Costs Of Leased And Rented Property Or Equipment
DirectCostsOfLeasedAndRentedPropertyOrEquipment
23858000 USD
CY2012Q1 us-gaap Direct Costs Of Leased And Rented Property Or Equipment
DirectCostsOfLeasedAndRentedPropertyOrEquipment
22716000 USD
CY2011Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2012Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2011Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2012Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2012Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
296731000 USD
CY2011Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
272390000 USD
CY2012Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8150000 USD
CY2011Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7308000 USD
CY2011Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
229000 USD
CY2012Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
1045000 USD
CY2011Q1 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
-866000 USD
CY2012Q1 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
-84000 USD
CY2011Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-21000 USD
CY2012Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1956000 USD
CY2011Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
2872000 USD
CY2012Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
3265000 USD
CY2012Q1 us-gaap Interest Paid
InterestPaid
9916000 USD
CY2011Q1 us-gaap Interest Paid
InterestPaid
10984000 USD
CY2011Q1 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
118000 USD
CY2012Q1 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
27000 USD
CY2012Q1 us-gaap Liabilities
Liabilities
918149000 USD
CY2011Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2291629000 USD
CY2012Q1 us-gaap Line Of Credit Facility Amount Outstanding
LineOfCreditFacilityAmountOutstanding
200000000 USD
CY2011Q4 us-gaap Line Of Credit Facility Amount Outstanding
LineOfCreditFacilityAmountOutstanding
0 USD
CY2012Q1 us-gaap Loans Assumed1
LoansAssumed1
0 USD
CY2011Q1 us-gaap Loans Assumed1
LoansAssumed1
6657000 USD
CY2012Q1 us-gaap Minority Interest In Net Income Loss Limited Partnerships
MinorityInterestInNetIncomeLossLimitedPartnerships
8000 USD
CY2011Q1 us-gaap Minority Interest In Net Income Loss Limited Partnerships
MinorityInterestInNetIncomeLossLimitedPartnerships
40000 USD
CY2012Q1 us-gaap Nature Of Operations
NatureOfOperations
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Organization and Description of Business</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Healthcare Trust of America, Inc., a Maryland corporation, was incorporated on April&#160;20, 2006. We were initially capitalized on April&#160;28, 2006 and consider that to be our date of inception. </font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We are a fully integrated, self-administered and internally managed real estate investment trust, or REIT, primarily focused on acquiring, owning and operating high-quality medical office buildings that are predominantly located on or aligned with campuses of nationally or regionally recognized healthcare systems. We are one of the largest public REITs focused on medical office buildings in the United States based on gross leasable area, or GLA, and have strong industry relationships, a stable and diversified tenant mix and an extensive and active acquisition network. Our primary objective is to maximize stockholder value with disciplined growth through strategic investments and to provide an attractive risk-adjusted return for our stockholders by consistently increasing our cash flow. In pursuing this objective, we target mid-sized acquisitions of high-quality medical office buildings in markets with dominant healthcare systems, attractive demographics and that complement our existing portfolio, actively manage our balance sheet to maintain flexibility with conservative leverage, and seek internal growth through proactive asset management, leasing and property management oversight. We have qualified to be taxed as a REIT for federal income tax purposes and we intend to continue to be taxed as a REIT. We conduct substantially all of our operations through Healthcare Trust of America Holdings, LP, or our operating partnership.</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We invest primarily in high-quality medical office buildings in our target markets, and have acquired high-quality medical office buildings and other facilities that serve the healthcare industry with an aggregate purchase price of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$2,548,860,000</font><font style="font-family:inherit;font-size:10pt;"> through </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March&#160;31, 2012</font><font style="font-family:inherit;font-size:10pt;">. As of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March&#160;31, 2012</font><font style="font-family:inherit;font-size:10pt;">, our portfolio consisted of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">245</font><font style="font-family:inherit;font-size:10pt;"> medical office buildings and 19 other facilities that serve the healthcare industry, as well as </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">two</font><font style="font-family:inherit;font-size:10pt;"> portfolios of mortgage loans receivable secured by medical office buildings.</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On September&#160;20, 2006, we commenced a best efforts initial public offering, or our initial offering, in which we offered up to </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">200,000,000</font><font style="font-family:inherit;font-size:10pt;"> shares of our common stock for </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$10.00</font><font style="font-family:inherit;font-size:10pt;"> per share in a primary offering and up to </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">21,052,632</font><font style="font-family:inherit;font-size:10pt;"> shares of our common stock pursuant to our distribution reinvestment plan, or the DRIP, at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$9.50</font><font style="font-family:inherit;font-size:10pt;"> per share, aggregating up to </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$2,200,000,000</font><font style="font-family:inherit;font-size:10pt;">. On March&#160;19, 2010, we commenced a best efforts follow-on public offering, or our follow-on offering, in which we offered up to </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">200,000,000</font><font style="font-family:inherit;font-size:10pt;"> shares of our common stock for </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$10.00</font><font style="font-family:inherit;font-size:10pt;"> per share in a primary offering and up to </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">21,052,632</font><font style="font-family:inherit;font-size:10pt;"> shares of our common stock pursuant to the DRIP at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$9.50</font><font style="font-family:inherit;font-size:10pt;"> per share, aggregating up to </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$2,200,000,000</font><font style="font-family:inherit;font-size:10pt;">. We stopped offering shares in the follow-on offering on February&#160;28, 2011. In aggregate, we received and accepted subscriptions in our initial and follow-on offerings for </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">220,673,545</font><font style="font-family:inherit;font-size:10pt;"> shares of our common stock, or </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$2,195,655,000</font><font style="font-family:inherit;font-size:10pt;">, excluding shares of our common stock issued under the DRIP. We continue to offer shares pursuant to the DRIP; however we may terminate the DRIP at any time. </font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our principal executive offices are located at 16435 N. Scottsdale Road, Suite 320, Scottsdale, Arizona, 85254. Our telephone number is (480)&#160;998-3478. For investor services, contact DST Systems, Inc. by telephone at (888)&#160;801-0107.</font></div></div>
CY2012Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
160338000 USD
CY2011Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
181497000 USD
CY2012Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-220814000 USD
CY2011Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-28472000 USD
CY2011Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
25110000 USD
CY2012Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
26105000 USD
CY2011Q1 us-gaap Net Income Loss
NetIncomeLoss
2150000 USD
CY2012Q1 us-gaap Net Income Loss
NetIncomeLoss
-315000 USD
CY2011Q4 us-gaap Notes And Loans Payable
NotesAndLoansPayable
639149000 USD
CY2012Q1 us-gaap Notes And Loans Payable
NotesAndLoansPayable
636466000 USD
CY2011Q4 us-gaap Notes Receivable Net
NotesReceivableNet
57459000 USD
CY2012Q1 us-gaap Notes Receivable Net
NotesReceivableNet
57431000 USD
CY2011Q4 us-gaap Off Market Lease Unfavorable
OffMarketLeaseUnfavorable
11832000 USD
CY2012Q1 us-gaap Off Market Lease Unfavorable
OffMarketLeaseUnfavorable
12899000 USD
CY2011Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
11914000 USD
CY2012Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
10699000 USD
CY2011Q4 us-gaap Other Assets
OtherAssets
56442000 USD
CY2012Q1 us-gaap Other Assets
OtherAssets
64541000 USD
CY2012Q1 us-gaap Other Liabilities
OtherLiabilities
23270000 USD
CY2011Q4 us-gaap Other Liabilities
OtherLiabilities
19930000 USD
CY2011Q4 us-gaap Other Restricted Assets
OtherRestrictedAssets
16718000 USD
CY2012Q1 us-gaap Other Restricted Assets
OtherRestrictedAssets
17927000 USD
CY2011Q1 us-gaap Payments For Previous Acquisition
PaymentsForPreviousAcquisition
0 USD
CY2012Q1 us-gaap Payments For Previous Acquisition
PaymentsForPreviousAcquisition
328000 USD
CY2011Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
7916000 USD
CY2012Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
9916000 USD
CY2012Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
4777000 USD
CY2011Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
1555000 USD
CY2011Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
19320000 USD
CY2012Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
22246000 USD
CY2011Q1 us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
56000 USD
CY2012Q1 us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
30000 USD
CY2011Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
15002000 USD
CY2012Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0 USD
CY2012Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
6695000 USD
CY2011Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
2548000 USD
CY2011Q1 us-gaap Payments To Acquire Real Estate
PaymentsToAcquireRealEstate
29733000 USD
CY2012Q1 us-gaap Payments To Acquire Real Estate
PaymentsToAcquireRealEstate
213900000 USD
CY2011Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2012Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2012Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
200000000 shares
CY2011Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
200000000 shares
CY2012Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2011Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2012Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2011Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2011Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2012Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2011Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
210210000 USD
CY2012Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
CY2011Q1 us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
125500000 USD
CY2012Q1 us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
0 USD
CY2011Q1 us-gaap Proceeds From Issuance Of Unsecured Debt
ProceedsFromIssuanceOfUnsecuredDebt
0 USD
CY2012Q1 us-gaap Proceeds From Issuance Of Unsecured Debt
ProceedsFromIssuanceOfUnsecuredDebt
200000000 USD
CY2012Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
182000000 USD
CY2011Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
0 USD
CY2011Q1 us-gaap Profit Loss
ProfitLoss
2190000 USD
CY2012Q1 us-gaap Profit Loss
ProfitLoss
-307000 USD
CY2012Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
225000 USD
CY2011Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
337000 USD
CY2011Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
1806471000 USD
CY2012Q1 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
1973458000 USD
CY2011Q1 us-gaap Real Estate Revenue Net
RealEstateRevenueNet
69243000 USD
CY2012Q1 us-gaap Real Estate Revenue Net
RealEstateRevenueNet
69935000 USD
CY2011Q4 us-gaap Redeemable Noncontrolling Interest Equity Fair Value
RedeemableNoncontrollingInterestEquityFairValue
3785000 USD
CY2012Q1 us-gaap Redeemable Noncontrolling Interest Equity Fair Value
RedeemableNoncontrollingInterestEquityFairValue
3690000 USD
CY2011Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
7000000 USD
CY2012Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
182000000 USD
CY2011Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
103496000 USD
CY2012Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
2563000 USD
CY2012Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-509066000 USD
CY2011Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-467249000 USD
CY2011Q1 us-gaap Revenues
Revenues
70892000 USD
CY2012Q1 us-gaap Revenues
Revenues
71243000 USD
CY2011Q1 us-gaap Share Based Compensation
ShareBasedCompensation
897000 USD
CY2012Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1002000 USD
CY2012Q1 us-gaap Stock Issued1
StockIssued1
19148000 USD
CY2011Q1 us-gaap Stock Issued1
StockIssued1
17651000 USD
CY2011Q1 us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
17651000 USD
CY2012Q1 us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
19148000 USD
CY2011Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
210210000 USD
CY2011Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 USD
CY2012Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 USD
CY2012Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
9916000 USD
CY2011Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
7916000 USD
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
1567340000 USD
CY2012Q1 us-gaap Stockholders Equity
StockholdersEquity
1535757000 USD
CY2011Q1 us-gaap Stockholders Equity
StockholdersEquity
1656705000 USD
CY2010Q4 us-gaap Stockholders Equity
StockholdersEquity
1487246000 USD
CY2012Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-508000 USD
CY2011Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
504000 USD
CY2012Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
228881454 shares
CY2011Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
214996502 shares
CY2012Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
228881454 shares
CY2011Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
214797450 shares
CY2012Q1 hta Accounts And Other Receivables Net
AccountsAndOtherReceivablesNet
12388000 USD
CY2011Q4 hta Accounts And Other Receivables Net
AccountsAndOtherReceivablesNet
12658000 USD
CY2012Q1 hta Depreciation And Amortization Including Deferred Financing Costs Above Below Market Leases Debt Discount Leasehold Interests Deferred Rent Receivable Note Receivable Closing Costs And Discount And Lease Inducements
DepreciationAndAmortizationIncludingDeferredFinancingCostsAboveBelowMarketLeasesDebtDiscountLeaseholdInterestsDeferredRentReceivableNoteReceivableClosingCostsAndDiscountAndLeaseInducements
26716000 USD
CY2011Q1 hta Depreciation And Amortization Including Deferred Financing Costs Above Below Market Leases Debt Discount Leasehold Interests Deferred Rent Receivable Note Receivable Closing Costs And Discount And Lease Inducements
DepreciationAndAmortizationIncludingDeferredFinancingCostsAboveBelowMarketLeasesDebtDiscountLeaseholdInterestsDeferredRentReceivableNoteReceivableClosingCostsAndDiscountAndLeaseInducements
23998000 USD
CY2012Q1 hta Distributions
Distributions
41502000 USD
CY2011Q1 hta Distributions
Distributions
38531000 USD
CY2012Q1 hta Distributions Declared But Not Paid Including Stock Issued Under Drip
DistributionsDeclaredButNotPaidIncludingStockIssuedUnderDrip
13229000 USD
CY2011Q1 hta Distributions Declared But Not Paid Including Stock Issued Under Drip
DistributionsDeclaredButNotPaidIncludingStockIssuedUnderDrip
13839000 USD
CY2011Q1 hta Real Estate Deposits Used
RealEstateDepositsUsed
3000000 USD
CY2011Q1 hta Restricted Cash And Escrow Deposits
RestrictedCashAndEscrowDeposits
-1309000 USD
CY2012Q1 hta Restricted Cash And Escrow Deposits
RestrictedCashAndEscrowDeposits
1209000 USD
CY2012Q1 dei Amendment Flag
AmendmentFlag
false
CY2012Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2012Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2012Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2012
CY2012Q1 dei Document Period End Date
DocumentPeriodEndDate
2012-03-31
CY2012Q1 dei Document Type
DocumentType
10-Q
CY2012Q1 hta Increase Decrease In Security Deposits Prepaid Rent And Other Liabilities
IncreaseDecreaseInSecurityDepositsPrepaidRentAndOtherLiabilities
3098000 USD
CY2011Q1 hta Increase Decrease In Security Deposits Prepaid Rent And Other Liabilities
IncreaseDecreaseInSecurityDepositsPrepaidRentAndOtherLiabilities
219000 USD
CY2012Q1 hta Interest Expense Related To Derivative Financial Instruments And Net Change Fair Value Of Derivative Financial Instruments
InterestExpenseRelatedToDerivativeFinancialInstrumentsAndNetChangeFairValueOfDerivativeFinancialInstruments
800000 USD
CY2011Q1 hta Interest Expense Related To Derivative Financial Instruments And Net Change Fair Value Of Derivative Financial Instruments
InterestExpenseRelatedToDerivativeFinancialInstrumentsAndNetChangeFairValueOfDerivativeFinancialInstruments
-144000 USD
CY2012Q1 hta Interest Expense Related To Mortgage Loans Payable And Credit Facility
InterestExpenseRelatedToMortgageLoansPayableAndCreditFacility
10233000 USD
CY2011Q1 hta Interest Expense Related To Mortgage Loans Payable And Credit Facility
InterestExpenseRelatedToMortgageLoansPayableAndCreditFacility
9986000 USD
CY2012Q1 hta Interest Income From Mortgage Notes Receivable And Other Income
InterestIncomeFromMortgageNotesReceivableAndOtherIncome
1308000 USD
CY2011Q1 hta Interest Income From Mortgage Notes Receivable And Other Income
InterestIncomeFromMortgageNotesReceivableAndOtherIncome
1649000 USD
CY2012Q1 hta Proceeds From Security Deposits
ProceedsFromSecurityDeposits
198000 USD
CY2011Q1 hta Proceeds From Security Deposits
ProceedsFromSecurityDeposits
132000 USD
CY2011Q1 hta Real Estate Deposits Paid
RealEstateDepositsPaid
500000 USD
CY2012Q1 hta Real Estate Deposits Paid
RealEstateDepositsPaid
2810000 USD
CY2012Q1 hta Real Estate Deposits Used
RealEstateDepositsUsed
3800000 USD
CY2012Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001360604
CY2012Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
230597292 shares
CY2012Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2012Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2011Q2 dei Entity Public Float
EntityPublicFloat
1624601000 USD
CY2012Q1 dei Entity Registrant Name
EntityRegistrantName
HEALTHCARE TRUST OF AMERICA, INC.
CY2012Q1 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2012Q1 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No

Files In Submission

Name View Source Status
0001445305-12-001771-index-headers.html Edgar Link pending
0001445305-12-001771-index.html Edgar Link pending
0001445305-12-001771.txt Edgar Link pending
0001445305-12-001771-xbrl.zip Edgar Link pending
a10qwrap.htm Edgar Link pending
a201q1cover.jpg Edgar Link pending
a201q1cover2.jpg Edgar Link pending
a201q1cover3.jpg Edgar Link pending
a201q1cover4.jpg Edgar Link pending
annualhealthcareexpbyageandp.jpg Edgar Link pending
annualizedbaserentduetolease.jpg Edgar Link pending
annualusexponhealthcare.jpg Edgar Link pending
annualvisitstpphysiciansoffi.jpg Edgar Link pending
arizonahealthcarespending.jpg Edgar Link pending
arizonapopulation.jpg Edgar Link pending
arizonapopulationbyagein2011.jpg Edgar Link pending
creditratingbasedonannualize.jpg Edgar Link pending
employmentgrowthandindustrye.jpg Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
georgiahealthcarespending.jpg Edgar Link pending
georgiapopulation.jpg Edgar Link pending
georgiapopulationbyage2011.jpg Edgar Link pending
hta-20120331.xml Edgar Link completed
hta-20120331.xsd Edgar Link pending
hta-20120331_cal.xml Edgar Link unprocessable
hta-20120331_def.xml Edgar Link unprocessable
hta-20120331_lab.xml Edgar Link unprocessable
hta-20120331_pre.xml Edgar Link unprocessable
hta2012033110-q.htm Edgar Link pending
hta20120331ex311.htm Edgar Link pending
hta20120331ex312.htm Edgar Link pending
hta20120331ex321.htm Edgar Link pending
hta20120331ex322.htm Edgar Link pending
hta_-xemploymentxagreement.htm Edgar Link pending
indianahealthcarespending.jpg Edgar Link pending
indianapopulation.jpg Edgar Link pending
indianapopulationbyage2011.jpg Edgar Link pending
inpatientadmissionsvoutpatie.jpg Edgar Link pending
massachusettshealthcarespend.jpg Edgar Link pending
massachusettspopulation.jpg Edgar Link pending
massachusettspopulationbyage.jpg Edgar Link pending
medicalofficeaskingrentalrat.jpg Edgar Link pending
medicalofficeconstructioncom.jpg Edgar Link pending
medicalofficevacancyvrentgro.jpg Edgar Link pending
oncampusoffcampusbldgtypev2.jpg Edgar Link pending
overviewofportfolio.jpg Edgar Link pending
pennsylvaniahealthcarespendi.jpg Edgar Link pending
pennsylvaniapopulation.jpg Edgar Link pending
pennsylvaniapopulationbyage2.jpg Edgar Link pending
presencein26states.jpg Edgar Link pending
putinplaceconstructionmedica.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
rentgrowthcomparison.jpg Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
southcarolinahealthcarespend.jpg Edgar Link pending
southcarolinapopulation.jpg Edgar Link pending
southcarolinapoulationbyage2.jpg Edgar Link pending
stewardpsaocrtext.htm Edgar Link pending
tenantmix.jpg Edgar Link pending
texashealthcarespending.jpg Edgar Link pending
texaspopulation.jpg Edgar Link pending
texaspopulationbyagein2011.jpg Edgar Link pending
top15healthcaresystems.jpg Edgar Link pending
totalreturnsandreturncompari.jpg Edgar Link pending
twentylargesttenantsbasedonr.jpg Edgar Link pending
usavglifeand65plus.jpg Edgar Link pending
usmedicalschoolmatriculants.jpg Edgar Link pending
uspopulation.jpg Edgar Link pending
uspopulation2010babyvecho.jpg Edgar Link pending
vacancyratecomparison.jpg Edgar Link pending